Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

SCAI blasts Medicare payment cuts to cardiology, asks members to take action

The group hopes its members can increase congressional support of a new bill introduced in the House. 

Sunil Rao, MD, FSCAI, 2022-23 President of the Society of Cardiovascular Angiography and Interventions (SCAI), and director of interventional cardiology NYU Langone, explains efforts by SCAI to address the shift in interventional procedures from hospitals to less expensive ambulatory surgical centers (ASC).

Maintaining quality is key as more cardiac procedures migrate to outpatient ASCs

SCAI President Sunil Rao, MD, discussed the group's efforts to address the shift in interventional procedures from hospitals to less expensive ambulatory surgical centers.

Eric Secemsky, MD, FACC, FAHA, FSCAI, FSVM, director of vascular intervention at Beth Israel Deaconess Medical Center, Boston, Massachusetts, presented the results of a real-world evidence study of data for over 1 million U.S. Medicare patients to evaluate trends in the use of, and outcomes associated with, intravascular imaging during percutaneous coronary interventions (PCI). #IVUS

Intravascular imaging-guided PCI boosts outcomes, but utilization remains low

Eric Secemsky, MD, told Cardiovascular Business that a lack of training is one of the biggest factors limiting the use of intravascular imaging-guided PCI among interventional cardiologists. 

Boston Scientific Acurate neo2 TAVR

ACURATE neo2 valve linked to successful commissural alignment during TAVR

The new Boston Scientific valve received CE mark approval in 2020, but has not been approved by the FDA.

Banner ASC in Sun City, Arizona.

PHOTO GALLERY: Behind the scenes at a cardiac ambulatory surgical center

A look inside a Banner Health cardiology ambulatory surgical center (ASC) in Sun City, Arizona.

Medtronic launches Evolut FX TAVR system aortic stenosis

New feature found on Evolut FX valve helps cardiologists confirm commissural alignment during TAVR

Commissural alignment is especially important now, researchers explained, because TAVR is being recommended for younger patients with longer life expectancies. 

SCAI President Sunil Rao, MD, explains the 2022-2023 SCAI accomplishments to improve interventional cardiology.

SCAI President Sunil Rao on how the society is helping advance interventional cardiology

Rao spoke with Cardiovascular Business at ACC.23 to detail some of SCAI's biggest accomplishments from the last year. 

Cardiologist Azeem Latib

Cardiologist Azeem Latib joins Supira Medical

The interventional cardiologist is now working with vendor Supira Medical to help advance the company's next-generation percutaneous ventricular assist device.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.